Health Canada - Federal department responsible for drug approvals and health regulation in Canada
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| M-MIDODRINE | mantra pharma inc | Marketed | Dec 17, 2024 | Marketed |
| SITAGLIPTIN | sanis health inc | Marketed | Dec 17, 2024 | Marketed |
| LURASIDONE | sanis health inc | Marketed | Dec 17, 2024 | Marketed |
| CARDALIS | CEVA ANIMAL HEALTH INC | Marketed | Dec 16, 2024 | Marketed |
| CARDALIS | CEVA ANIMAL HEALTH INC | Marketed | Dec 16, 2024 | Marketed |
| RIVAROXABAN | sanis health inc | Marketed | Dec 13, 2024 | Marketed |
| RIVAROXABAN | sanis health inc | Marketed | Dec 13, 2024 | Marketed |
| RIVAROXABAN | sanis health inc | Marketed | Dec 13, 2024 | Marketed |
| RIVAROXABAN | sanis health inc | Marketed | Dec 13, 2024 | Marketed |
| JAMP LEVOCARB | Jamp Pharma Corporation | Marketed | Dec 13, 2024 | Marketed |
| JAMP LEVOCARB | Jamp Pharma Corporation | Marketed | Dec 13, 2024 | Marketed |
| JAMP LEVOCARB | Jamp Pharma Corporation | Marketed | Dec 13, 2024 | Marketed |
| MICAFUNGIN SODIUM FOR INJECTION | omega laboratories limited | Marketed | Dec 12, 2024 | Marketed |
| ULTRA GENTLE DAILY FACIAL MOISTURIZER SPF 30 | johnson & johnson inc | Marketed | Dec 11, 2024 | Marketed |
| PRO-LISDEXAMFETAMINE | PRO DOC LIMITEE | Marketed | Dec 10, 2024 | Marketed |
| MOUNJARO KWIKPEN | eli lilly canada inc | Marketed | Dec 10, 2024 | Marketed |
| PRO-LISDEXAMFETAMINE | PRO DOC LIMITEE | Marketed | Dec 10, 2024 | Marketed |
| MOUNJARO KWIKPEN | eli lilly canada inc | Marketed | Dec 10, 2024 | Marketed |
| MOUNJARO KWIKPEN | eli lilly canada inc | Marketed | Dec 10, 2024 | Marketed |
| MOUNJARO KWIKPEN | eli lilly canada inc | Marketed | Dec 10, 2024 | Marketed |
